Product manufactured by Nexgen Pharma, Inc.

Application Nr Approved Date Route Status External Links
ANDA091019 2009-10-22 Oral RX Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Chenodiol Is Indicated For Patients With Radiolucent Stones In Well-Opacifying Gallbladders, In Whom Selective Surgery Would Be Undertaken Except For The Presence Of Increased Surgical Risk Due To Systemic Disease Or Age. The Likelihood Of Successful Dissolution Is Far Greater If The Stones Are Floatable Or Small. For Patients With Nonfloatable Stones, Dissolution Is Less Likely And Added Weight Should Be Given To The Risk That More Emergent Surgery Might Result Form A Delay Due To Unsuccessful Treatment. Safety Of Use Beyond 24 Months Is Not Established. Chenodiol Will Not Dissolve Calcified (radiopaque) Or Radiolucent Bile Pigment Stones.

All Formulated Excipients (0 Total)


Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Chenodiol CHENODIOL ZINC3914808